Are You Familiar With Alberta’s Updated Price Policy?

The update touches the Alberta Price Confirmation, the pan-Canadian generic initiative price confirmation, the fixed pricing rule, the least cost alternative policy and the maximum allowable cost policy…Read more. (Source: Canadian Market Access, 2/19/14).

You might also be interested in:

HHS Plans to Implement 340B Final Rule in January November 1, 2018
ICER’s Updated Assessment of New Targeted Therapies for… June 13, 2018
ICER Releases Final New Evidence Update for Alirocumab February 15, 2019
ICER Releases Updated Report on Targeted Treatments for Plaque… August 5, 2018
Research Suggests Low-Cost Generics at High Risk of Shortages December 14, 2018
FDA Moves on Biosimilars, Outlines New Plans December 15, 2018
NPC: Alternative Perspectives Welcome in Value Assessment December 18, 2018